Acquisition / mergerFiled on BSE ·
Meghmani Organics receives NCLT order approving merger with subsidiaries
Meghmani Organi. · Fertilizers & Agrochemicals
What the filing says
- NCLT Ahmedabad sanctioned Scheme of Amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition with Meghmani Organics on October 9, 2026
- Scheme approved under sections 230-232 of Companies Act, 2013, effective upon filing with Registrar of Companies, Ahmedabad
- Meghmani Organics is the transferee company; Kilburn Chemicals and Meghmani Crop Nutrition are wholly owned transferor subsidiaries
Original filing
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Meghmani Organi.
- Acquisition / mergerMeghmani Organics Limited announces NCLT sanction of merger with subsidiaries
Other acquisition / merger filings this fortnight
- Acquisition / mergerL. T. Elevator LtdL.T. Elevator Limited approves preferential allotment of 4.61 lakh equity shares
- Acquisition / mergerTriven.Engg.Ind.Triveni Power Transmission Ltd gets equity shares listing approval on BSE and NSE
- Acquisition / mergerClean Max EnviroClean Max Enviro Energy Solutions to acquire 100% of Massmunch Company Limited
- Acquisition / mergerNBCCNBCC (India) Ltd announces MCA order on Scheme of Merger with HSCC (India) Ltd
- Acquisition / mergerShakti PumpsShakti Pumps invests ₹10 crore in wholly owned subsidiary Shakti Energy Solutions
- Acquisition / mergerElevate Campuses LtdElevate Campuses Limited subscribes to Class A OCRPS in Elevate UAE for ₹601 crore
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.